THRIFT. Risk of and prophylaxis for venous thromboembolism in hospital patients. Br Med J1992; 305: 567–74.
3.
MorrellM TDunnillM S. The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg1968; 55: 347–52.
4.
CoonW WWillisP WKellerJ B. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation1973; 48839–46.
5.
AndersonF AWheelerBGoldbergR JHosmerD W. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med1991; 151: 933–38.
6.
NordstromMLindbladBBergqvistDKjellstromT. A prospective study of the incidence of deep vein thrombosis within a defined urban population. J Intern Med1992; 232: 155–60.
7.
European Consensus Statement. Prevention of venous thromboembolism. Int Angiol1992; 11: 151–59.
8.
GillumR F. Pulmonary embolism and thrombophlebitis in the United States, 1970–1985. Am Heart J1987; 114: 1262–64.
9.
CarsonJ LKelleyM ADuffA. The clinical course of pulmonary embolism. N Engl J Med1992; 326: 1240–45.
10.
FerriarJ. Medical histories and reflections. London: Cadell and Davies, 1810: 169.
11.
WarlowC POgstonDDouglasA S. Deep venous thrombosis of the legs after strokes. Part I—Incidence and predisposing factors. Part 2—Natural history. Br Med J1976; 1: 1178–83.
12.
BoccardiECandeliseLLandiGOrazioNobile E. Incidence of deep vein thrombosis in acute hemispheric stroke. 6th International Congress on Thrombosis and Haemostasis, 1980.
13.
ViitanenMWimbladBAsplundK. Autopsy-verified causes of death after stroke. Acta Med Scand1987; 222: 401–408.
14.
GoldhaberS Z. Pulmonary embolism and deep venous thrombosis. Philadelphia: WB Saunders, 1985.
15.
CopeCReyesT MSkverskyN J. Phlebographic analysis of the incidence of thrombosis in hemiplegia. Radiology1973; 109: 581–84.
16.
LaneD ASolffSIrelandHGawelMFoadiM. Activation of coagulation and fibrinolytic systems following stroke. Br J Haematol1983; 53: 655–58.
17.
NicolaidesAKakkarV VFieldE SFishP. Optimal electrical stimulus for prevention of deep vein thrombosis. Br Med J1972; 3: 756–58.
18.
OsbornS BWrightH P. Br J Radiol1949; 110:••.
19.
AllenbyFBoardmanLPflugJ JCalnanJ S. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet1973; ii: 1412–13.
20.
WellsP SLensingA W AHirshJ. Graduated compression stockings in the prevention of postoperative venous thromboembolism: A metaanalysis. Arch Intern Med1994; 154: 67–72.
21.
TurpieA GHirshJGentMJulianDJohnsonJ. Prevention of deep vein thrombosis in potential neurosurgical patients; a randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med1989; 149: 679–81.
22.
HirshJGentonEHullR D. Venous thromboembolism. New York; Grune & Stratton, 1981.
23.
PrasadB KBanerjeeA KHowardH. Incidence of deep venous thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics. Age Ageing1982; 11: 42–44.
24.
CounsellC ESandercockP A G. The efficacy and safety of anticoagulant therapy in patients with presumed ischaemic stroke: A systematic review of the randomized trial comparing anticoagulants with control. Cochrane Database of Systematic Reviews1995; issue 2.
25.
SandercockP A GVan-Den-BeltA G MLindleyR ISlatteryJ M. Antithrombotic therapy in acute ischaemic stroke: An overview of the completed randomised trials. J Neurol Neurosurg Psychiatry1993; 56: 17–25.
26.
DickmannUVothESchichaHHenzeT. Heparin therapy, deep vein thrombosis and pulmonary embolism after intracerebral haemorrhage. Klin Wochenschr1988; 66: 1182–83.
27.
LeizoroviczAHaughM CChapuisF-RSamamaMBoisselJ P. Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J1992; 305: 913–20.
28.
CounsellC ESandercockP A G. The use of low-molecular-weight heparins or heparinoids compared to standard unfractionated heparin in acute ischaemic stroke: A systematic review of the trials. Cochrane Database of Systematic Reviews1995; issue 2.
29.
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet treatment. Part III: Reduction in pulmonary embolism and venous thrombosis by antiplatelet prophylaxis among surgical and medical patients. Br Med J1994; 308: 235–46.
30.
CounsellC ESandercockP A G. The efficacy and safety of antiplatelet therapy in acute presumed ischaemic stroke: A systematic review of the randomized trials comparing immediate antiplatelet therapy with control. Cochrane Database of Systematic Reviews1995; issue 2.
31.
MellbringGStrandTErikssonS E. Venous thromboembolism after cerebral infarction and the prophylactic effect of Dextran 40. Acta Med Scand1986; 220: 425–29.
32.
DenhamM JFarranHJamesG. The value of I125 fibrinogen in the diagnosis of deep venous thrombosis in hemiplegia. Age Ageing1973; 2: 207–210.
33.
BrownMGlassenbergM. Mortality factors in patients with acute stroke. J Am Med Assoc1973; 224: 1493–95.
34.
BoundsJ VWiebersD OWhisnantJ POkazakiH. Mechanism and timing of deaths from cerebral infarction. Stroke1981; 12: 474–77.
35.
BamfordJ MDennisM SSandercockP A GBurnJ P SWarlowC P. The frequency, causes and timing of death within 30 days of a first stroke. J Neurol Neurosurg Psychiatry1990; 53: 824–29.
36.
SilverF LNorrisJ WLewisA JHachinskiV. Early mortality following stroke: A prospective review. Stroke1984; 15: 492–96.
37.
OppenheimerSHachinskiV. Complications of acute stroke. Lancet1992; 339: 721–24.